Burning Rock Biotech (BNR) Current Assets (2019 - 2025)
Burning Rock Biotech has reported Current Assets over the past 7 years, most recently at $104.1 million for Q4 2025.
- For Q4 2025, Current Assets fell 3.68% year-over-year to $104.1 million; the TTM value through Dec 2025 reached $104.1 million, down 3.68%, while the annual FY2025 figure was $105.6 million, 0.73% down from the prior year.
- Current Assets for Q4 2025 was $104.1 million at Burning Rock Biotech, roughly flat from $103.9 million in the prior quarter.
- Over five years, Current Assets peaked at $367.9 million in Q1 2021 and troughed at $103.4 million in Q2 2025.
- A 5-year average of $179.6 million and a median of $141.4 million in 2023 define the central range for Current Assets.
- Biggest five-year swings in Current Assets: plummeted 38.44% in 2022 and later dropped 3.68% in 2025.
- Year by year, Current Assets stood at $284.8 million in 2021, then plummeted by 37.86% to $177.0 million in 2022, then crashed by 30.62% to $122.8 million in 2023, then dropped by 11.95% to $108.1 million in 2024, then fell by 3.68% to $104.1 million in 2025.
- Business Quant data shows Current Assets for BNR at $104.1 million in Q4 2025, $103.9 million in Q3 2025, and $103.4 million in Q2 2025.